LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells

Cancer Science

Volumn 100, Issue 12, 2009, Pages 2335-2340

  Liu, Xinrong ^a,b   Xiong, Fuxia ^a   Wei, Xuanhui ^a   Yang, Hua ^a   Zhou, Rouli ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN E; LYSOSOMAL PROTEIN TRANSMEMBRANE 4 BETA; LYSOSOMAL PROTEIN TRANSMEMBRANE 4 BETA 35; MEMBRANE PROTEIN; MYC PROTEIN; PROTEIN C FOS; PROTEIN C JUN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL; CELL CYCLE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; METASTASIS POTENTIAL; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; TRANSCRIPTION REGULATION; UPREGULATION;

AGED; AMINO ACID MOTIFS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; NEOPLASM METASTASIS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 70649109763     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01346.x     Document Type: Article

References (33)

1. Shao GZ, Zhou RL, Zhang QY. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Oncogene 2003, 22:5060-9.
2. Liu XR, Zhou RL, Zhang QY. Structure analysis and expressions of a novel tetratransmembrane protein, lysosome-associated protein transmembrane 4 beta associated with hepatocellular carcinoma. World J Gastroenterol 2004, 10:1555-9.
3. Hogue DL, Ellison MJ, Young JD, Cass CE. Identification of a novel membrane transporter associated with intracellular membranes by phenotypic complementation in the yeast Saccharomyces cerevisiae. J Biol Chem 1996, 271:9801-8.
4. Cabrita MA, Hobman TC, Hogue DL. Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes. Cancer Res 1999, 59:4890-7.
5. Kasper G, Vogel A, Klaman I. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Cancer Lett 2005, 224:93-103.
6. Morris DG, Musat M, Czirjak S. Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 2005, 153:143-51.
7. Peng C, Zhou RL, Shao GZ. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. World J Gastroenterol 2005, 11:2704-8.
8. Zhou L, He XD, Chen J. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma. Eur J Cancer 2007, 43:809-15.
9. Zhou L, He XD, Cui QC. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. Cancer Lett 2008, 264:209-17.
10. Yang Y, Yang H, McNutt MA. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma. Oncol Rep 2008, 20:1077-83.
11. Yang H, Xiong FX, Lin M. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol 2009, doi
12. Dillon RL, White DE, Muller WJ. The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene 2007, 26:1338-45.
13. Dor I, Namba M, Sato J. Establishment and some biological characteristics of human hepatoma cell lines. Gann = Gan 1975, 66:385-92.
14. Yang TT, Sinai P, Kain SR. An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells. Anal Biochem 1996, 241:103-8.
15. Salvi A, Arici B, De Petro G, Barlati S. Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells. Mol Cancer Ther 2004, 3:671-8.
16. Kleinman HK, McGarvey ML, Hassell JR. Basement membrane complexes with biological activity. Biochemistry 1986, 25:312-18.
17. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70.
18. Gartel AL, Shchors K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 2003, 283:17-21.
19. Popescu NC, Zimonjic DB. Chromosome-mediated alterations of the MYC gene in human cancer. J Cell Mol Med 2002, 6:151-9.
20. Wu CH, Sahoo D, Arvanitis C. Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis. PLoS Genet 2008, 4:e1000090.
21. Takahashi Y, Kawate S, Watanabe M. Amplification of c-myc and cyclin D1 genes in primary and metastatic carcinomas of the liver. Pathol Int 2007, 57:437-42.
22. Chan KL, Guan XY, Ng IO. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma. Hum Pathol 2004, 35:1324-31.
23. Greenbaum LE. Cell cycle regulation and hepatocarcinogenesis. Cancer Biol Ther 2004, 3:1200-7.
24. Bernard S, Eilers M. Control of cell proliferation and growth by Myc proteins. Results Probl Cell Differ 2006, 42:329-42.
25. Gee JM, Barroso AF, Ellis IO. Biological and clinical associations of c-jun activation in human breast cancer. Int J Cancer 2000, 89:177-86.
26. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 2005, 41:2449-61.
27. Bamberger AM, Milde-Langosch K, Rossing E. Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol 2001, 127:545-50.
28. Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene 2001, 20:2401-12.
29. Tavtigian SV, Zabludoff SD, Wold BJ. Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression. Mol Biol Cell 1994, 5:375-88.
30. Perez-Roger I, Solomon DL, Sewing A, Land H. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 1997, 14:2373-81.
31. Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994, 14:1669-79.
32. Li SS. Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 2005, 390:641-53.
33. Kaneko T, Li L, Li SS. The SH3 domain - a family of versatile peptide- and protein-recognition module. Front Biosci 2008, 13:4938-52.